BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2616268)

  • 1. Molecular diagnosis of chronic myeloid leukemia using a 3'bcr probe.
    Berthéas MF; Vindimian M; Ollagnon G; Pomier G; Jaubert J; Vasselon C; Reynaud J; Heally JC; Le Petit JC; Brizard CP
    Nouv Rev Fr Hematol (1978); 1989; 31(6):393-5. PubMed ID: 2616268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
    González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
    Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCR rearrangements in Ph positive chronic myelocytic leukemia.
    Deng DS; Yang AD; Gong WL; Fei HB; Liu SM
    Chin Med J (Engl); 1991 Aug; 104(8):658-63. PubMed ID: 1680611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diagnosis of Philadelphia chromosome-positive chronic myeloid leukemia.
    Zaccaria A; Tassinari A; Guerrasio A; Rosso C; Lo Coco F; Diverio D; Testoni N; Celso B; Buzzi M; Tura S
    Haematologica; 1991; 76(3):183-7. PubMed ID: 1660437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].
    Xue YQ
    Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
    Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
    Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular study of Ph1 chromosome negative chronic myelocytic leukemia].
    Chen S
    Zhonghua Yi Xue Za Zhi; 1991 Aug; 71(8):425-7, 30. PubMed ID: 1660759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of pulsed field gel electrophoresis to characterize BCR gene involvement in CML patients lacking M-BCR rearrangement.
    Min GL; Martiat P; Pu GA; Goldman J
    Leukemia; 1990 Sep; 4(9):650-6. PubMed ID: 2395384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakpoint cluster region (BCR) gene rearrangement studies in chronic myeloid and acute lymphoblastic leukemias.
    Chin YM; Bosco JJ; Koh CL
    Med J Malaysia; 1992 Jun; 47(2):110-3. PubMed ID: 1494330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minor BCR (m-bcr) rearrangements may appear in major BCR (M-bcr)-positive CML cases.
    Karlic H; Grill R; Schlögl E
    Hematol Pathol; 1992; 6(4):203-7. PubMed ID: 1362728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex variant Philadelphia translocations involving the short arm of chromosome 6 in chronic myeloid leukemia.
    La Starza R; Testoni N; Lafage-Pochitaloff M; Ruggeri D; Ottaviani E; Perla G; Martelli MF; Marynen P; Mecucci C
    Haematologica; 2002 Feb; 87(2):143-7. PubMed ID: 11836164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of cytogenetic and molecular biology in the detection of chronic myeloid leukemia].
    Michalová K; Zemanová Z; Haskovec C; Rypácková B; Brdicka R
    Cas Lek Cesk; 1992 Dec; 131(24-25):729-32. PubMed ID: 1288873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fluorescent in-situ hybridization technique (FISH) in the diagnosis of Philadelphia translocation in chronic myeloid leukemia].
    Martinet D; Mühlematter D; Jotterand Bellomo M
    Schweiz Med Wochenschr; 1996 May; 126(20):855-63. PubMed ID: 8685681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular analysis in 13 cases of chronic Philadelphia-positive myeloid leukemia].
    Valiente A; Benítez J; Pérez Sáenz MA; Sánchez Fayos J
    Sangre (Barc); 1989 Dec; 34(6):481-4. PubMed ID: 2629125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of the bcr/abl probe test in the evaluation of chronic myeloid leukemia patients.
    Yazici H; Sengün Z; Aktan M; Aktuglu G; Uskent N; Dalay N
    J Exp Clin Cancer Res; 1997 Mar; 16(1):105-9. PubMed ID: 9148870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakpoint cluster region, immunoglobulin, and T-cell receptor gene rearrangement analysis in juvenile chronic myelogenous leukemia.
    Farhi DC; Luckey CN; Siddiqui AM
    Mod Pathol; 1995 May; 8(4):389-93. PubMed ID: 7567936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
    Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial insertion of varying amounts of ABL-containing genetic material into chromosome 22 in Ph-negative CML.
    Rassool F; Martiat P; Taj A; Klisak I; Goldman J
    Leukemia; 1990 Apr; 4(4):273-7. PubMed ID: 2164119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia.
    Blennerhassett GT; Furth ME; Anderson A; Burns JP; Chaganti RS; Blick M; Talpaz M; Dev VG; Chan LC; Wiedemann LM
    Leukemia; 1988 Oct; 2(10):648-57. PubMed ID: 3050293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular analysis of chronic Philadelphia chromosome negative myeloid leukemia: study of 6 cases].
    Cervantes F; Urbano-Ispizua A; Pujades A; Bosch F; Vives-Corrons JL; Montserrat E; Rozman C
    Med Clin (Barc); 1992 Sep; 99(8):286-8. PubMed ID: 1453821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.